Molecular Biology of the Cell Call for Nominations: MBC Editor-in-Chief

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
QUICK SEARCH:   [advanced]


     

MBC in Press, published online ahead of print April 11, 2007
Mol. Biol. Cell 10.1091/mbc.E06-09-0844

A more recent version of this article appeared on June 1, 2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
E06-09-0844v1
18/6/2367    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kannemeier, C.
Right arrow Articles by Sun, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kannemeier, C.
Right arrow Articles by Sun, P.

Submitted on September 21, 2006
Revised on March 26, 2007
Accepted on April 2, 2007

The RING Finger Domain of MDM2 Is Essential for MDM2-mediated TGF-{beta} Resistance

Christian Kannemeier, Rong Liao, and Peiqing Sun

Department of Molecular Biology, MB-41, The Scripps Research Institute, La Jolla, CA 92037

Monitoring Editor: Gerard Evan

In this study, we attempt to gain insights into the molecular mechanism underlying MDM2-mediated TGF-{beta} resistance. MDM2 renders cells refractory to TGF-{beta} by overcoming a TGF-{beta}-induced G1 cell cycle arrest. Because the TGF-{beta} resistant phenotype is reversible upon removal of MDM2, MDM2 likely confers TGF-{beta} resistance by directly targeting the cellular machinery involved in the growth inhibition by TGF-{beta}. Investigation of the structure-function relationship of MDM2 reveals three elements essential for MDM2 to confer TGF-{beta} resistance in both mink lung epithelial cells and human mammary epithelial cells. One of these elements is the C-terminal half of the p53-binding domain, which at least partially retained p53-binding and -inhibitory activity. Second, the ability of MDM2 to mediate TGF-{beta} resistance is disrupted by mutation of the nuclear localization signal, but is restored upon coexpression of MDMX, Finally, mutations of the zinc coordination residues of the RING finger domain abrogates TGF-{beta} resistance, but not the ability of MDM2 to inhibit p53 activity or to bind MDMX. These data suggest that RING finger-mediated p53 inhibition and MDMX interaction are not sufficient to cause TGF-{beta} resistance, and imply a crucial role of the E3 ubiquitin ligase activity of this domain in MDM2-mediated TGF-{beta} resistance.

Address correspondence to: Peiqing Sun (pqsun{at}scripps.edu)




This article has been cited by other articles:


Home page
 Cancer Res.Home page
M. Maguire, P. C. Nield, T. Devling, R. E. Jenkins, B. K. Park, R. Polanski, N. Vlatkovic, and M. T. Boyd
MDM2 Regulates Dihydrofolate Reductase Activity through Monoubiquitination
Cancer Res., May 1, 2008; 68(9): 3232 - 3242.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Copyright © 2007 by The American Society for Cell Biology. Terms of copyright protection, warranties, and disclaimers.